登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Viable CD109+ CECs and CD146+CECs before and after treatment.
Viable CD109+ CECs and CD146+CECs before and after treatment.
收藏
Figshare
2015-12-02 更新
2026-04-29 收录
循环内皮细胞
治疗反应监测
数据链接：
https://figshare.com/articles/dataset/_Viable_CD109_CECs_and_CD146_CECs_before_and_after_treatment_/1271704
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Viable CD109+ CECs and CD146+CECs before and after treatment.
应用场景：
创建时间：
2015-12-02
相关数据集
Characteristics of patients with low versus high vancomycin levels in the entire cohort.
治疗反应监测
万古霉素个体化用药
Characteristics of patients with low versus high vancomycin levels in the entire cohort.
NIAID Data Ecosystem
5
0
Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
肿瘤个体化用药
治疗反应监测
Regorafenib has demonstrated a significant benefit in overall survival in metastatic colorectal cancer (mCRC) patients. However, more than 50% of patients had severe adverse events (grade 3-4), leadin
NIAID Data Ecosystem
3
0
CVC Plasma Trough Levels (Mean±SD).
治疗反应监测
药代动力学数据
CVC Plasma Trough Levels (Mean±SD).
Figshare
2016-10-27 更新
2
0
Characteristics of patients with low versus high vancomycin levels in the entire cohort.
治疗反应监测
万古霉素药代动力学
Characteristics of patients with low versus high vancomycin levels in the entire cohort.
Figshare
2019-04-04 更新
3
0
Additional file 1 of Acute-on-chronic liver failure alters linezolid pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
重症药代动力学
治疗反应监测
Additional file 1: Table S1. Linezolid Concentrations at Time Points.
Figshare
2024-08-13 更新
2
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
